Role of Intensity-Modulated Radiotherapy in Reducing Toxicity in Dose Escalation for Localized Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 3, 2009, Pages 685-691

  Al Mamgani, Abrahim ^a   Heemsbergen, Wilma D ^b   Peeters, Stephanie T H ^b   Lebesque, Joos V ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Dose escalation; IMRT; Intensity modulated radiotherapy; Prostate cancer; Randomized trial; Toxicity

Indexed keywords

PATIENT MONITORING; PHYSICAL THERAPY; RADIOTHERAPY;

DOSE ESCALATION; IMRT; INTENSITY-MODULATED RADIOTHERAPY; PROSTATE CANCER; RANDOMIZED TRIAL;

TOXICITY;

AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RISK REDUCTION; TOXICITY; TREATMENT FAILURE; UROGENITAL TRACT DISEASE;

AGED; GASTROINTESTINAL TRACT; HUMANS; MALE; NETHERLANDS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; TIME FACTORS; URINARY BLADDER; UROGENITAL SYSTEM;

EID: 59649101083     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.063     Document Type: Article

References (22)

1. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1239
2. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
3. Dearnaley D.P., Hall E., Lawrence D., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. B J Cancer 92 (2005) 488-498
4. Al-Mamgani A, van Putten WLJ, Heemsbergen WD, et al. Update of the Dutch multicenter dose escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. In press.
5. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial. Lancet 353 (1999) 267-272
6. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
7. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150 (1993) 110-114
8. Bos L.J., Damen E.M.F., de Boer R.W., et al. Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. Int J Radiat Oncol Biol Phys 52 (2002) 254-265
9. Bel A., Vos P.H., Rodrigus P.T., et al. High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys 35 (1996) 321-332
10. Peeters S.T., Heemsbergen W.D., van Putten W.L., et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
11. Peeters S.T.H., Lebesque J.V., Heemsbergen W.D., et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1151-1161
12. Peeters S.T.H., Hoogeman M.S., Heemsbergen W.D., et al. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1142-1152
13. Harsolia A., Vargas C., Yan D., et al. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: Dose-volume analysis of a phase II dose-escalation study. Int J Radiat Oncol Biol Phys 69 (2007) 1100-1109
14. Hoogeman M.S., Peeters S.T.H., de Bois J., et al. Absolute and relative dose-surface and dose-volume histograms of the bladder: which one is the most invariant under bladder filling changes?. Phys Med Biol 50 (2005) 3589-3597
15. Heemsbergen W.D., Peeters S.T.H., Koper P.C., et al. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: Consequential late damage. Int J Radiat Oncol Biol Phys 60 (2006) 3-10
16. Denham J.W., O'Brien P.C., Dunstan R.H., et al. Is there more than one late radiation proctitis syndrome?. Radiother Oncol 51 (1999) 43-53
17. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1124-1129
18. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
19. Michalski J.M., Purdy J.A., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 46 (2000) 391-402
20. Cheung M.R., Tucker S.L., Dong L., et al. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67 (2007) 1059-1065
21. Koper P.C., Jansen P., van Putten W., et al. Gastrointestinal and genitourinary morbidity after 3D conformal radiotherapy of prostate cancer: Observations of a randomized trial. Int J Radiat Oncol Biol Phys 73 (2004) 1-9
22. Bos L.J., van der Geer J., van Herk M., et al. The sensitivity of dose distributions for organ motion and set-up uncertainties in prostate IMRT. Radiother Oncol 76 (2005) 18-26